Institution
Cleveland Clinic Abu Dhabi
- 11running trials
- 5closed trials
- 3,742publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 Carriers
Recruiting
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Recruiting
Active, not recruiting
Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke3 recruiting
- ALS (motor neurone disease)1 recruiting
- Alzheimer disease1 recruiting
- Atrial fibrillation1 recruiting
- Brain aneurysm1 recruiting
- Heart failure1 recruiting
- Lupus (SLE)1 recruiting
- Rheumatoid arthritis1 recruiting
- Spinal cord injury1 recruiting
Closed trials
Withdrawn
Recruiting
Completed
Completed
Completed
Registry name variants (6)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Cleveland Clinic Abu Dhabi
Abu Dhabi, 112412
11 trials
Cleveland Clinic Abu Dhabi (CCAD)
Abu Dhabi, 112412
1 trial
Contact: Florian Roser, MD, PhD (principal investigator)
Cleveland Clinic Abu Dhabi
Abu Dhabi
1 trial
Cleveland Clinic Abu Dhabi
Abu Dhabi
1 trial
Cleveland Clinic Abu Dhabi
Abu Dhabi
1 trial
Cleveland Clinic Abu Dhabi (Site 2650)
Abu Dhabi, Abu Dhabi Emirate 112412
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Neuromyelitis optica (NMOSD)6 works · 0 trials
- Chronic spontaneous urticaria6 works · 0 trials
- Trigeminal neuralgia3 works · 0 trials
Institution data: ROR 00042rr39 (CC0-1.0)Updated 15 Nov 2026